Skip to Content

TEVA 7335 (Topiramate (Sprinkle) 15 mg)

Pill with imprint TEVA 7335 is White, Capsule-shape and has been identified as Topiramate (Sprinkle) 15 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of migraine prevention; bipolar disorder; seizures; seizure prevention; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7335

Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335

Topiramate (Sprinkle)

Imprint:
TEVA 7335
Strength:
15 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide